Cargando…

New Insights into Biology, Prognostic Factors, and Current Therapeutic Strategies in Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is characterized by the clonal proliferation and accumulation of mature B lymphocytes. CLL cells show an antiapoptotic profile, suggesting the important role of apoptosis inhibition in the disease development. However, there is some population of proliferating CLL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smolewski, Piotr, Witkowska, Magdalena, Korycka-Wołowiec, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763269/ https://www.ncbi.nlm.nih.gov/pubmed/24027642 http://dx.doi.org/10.1155/2013/740615

Ejemplares similares

The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions
por: Robak, Tadeusz, et al.
Publicado: (2022)

Helicobacter pylori Infection, Chronic Inflammation, and Genomic Transformations in Gastric MALT Lymphoma
por: Witkowska, Magdalena, et al.
Publicado: (2013)

Inhibition of the PI3K/Akt/mTOR Signaling Pathway in Diffuse Large B-Cell Lymphoma: Current Knowledge and Clinical Significance
por: Majchrzak, Agata, et al.
Publicado: (2014)

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas
por: Witkowska, Magdalena, et al.
Publicado: (2018)

The Role of Radiotherapy in Hodgkin's Lymphoma: What Has Been Achieved during the Last 50 Years?
por: Witkowska, Magdalena, et al.
Publicado: (2015)

Current and future treatment strategies in chronic lymphocytic leukemia
por: Patel, Krish, et al.
Publicado: (2021)

Refractory chronic lymphocytic leukemia – new therapeutic strategies
por: Schnaiter, Andrea, et al.
Publicado: (2010)

Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies
por: Kikushige, Yoshikane
Publicado: (2020)

RUNX1 and RUNX3 Genes Expression Level in Adult Acute Lymphoblastic Leukemia—A Case Control Study
por: Szmajda-Krygier, Dagmara, et al.
Publicado: (2022)

Atypical Chronic Lymphocytic Leukemia—The Current Status
por: Robak, Tadeusz, et al.
Publicado: (2023)

Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
por: Roy Chowdhury, Subir, et al.
Publicado: (2018)

Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies
por: Delgado, Julio, et al.
Publicado: (2020)

Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia
por: Cavallari, Maurizio, et al.
Publicado: (2018)

Therapeutic advancement of chronic lymphocytic leukemia
por: Lu, Kang, et al.
Publicado: (2012)

Therapeutic Targets in Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2020)

Cytotoxic Activity of Melatonin Alone and in Combination with Doxorubicin and/or Dexamethasone on Diffuse Large B-Cell Lymphoma Cells in In Vitro Conditions
por: Mańka, Sylwia, et al.
Publicado: (2023)

Chronic lymphocytic leukemia-associated paraneoplastic pemphigus: potential cause and therapeutic strategies
por: Cao, Lei, et al.
Publicado: (2020)

Prognostic Role of Lymphocyte/Monocyte Ratio in Chronic Lymphocytic Leukemia
por: Yokus, Osman, et al.
Publicado: (2020)

Association of variants in BAFF (rs9514828 and rs1041569) and BAFF-R (rs61756766) genes with the risk of chronic lymphocytic leukemia
por: Jasek, Monika, et al.
Publicado: (2016)

Highlights: B-chronic lymphocytic leukemia: Current diagnostic characteristics of and treatments for chronic lymphocytic leukemia in Japan
por: Aoki, Sadao
Publicado: (2020)

COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges
por: Charra, Boubaker, et al.
Publicado: (2020)

Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
por: Robak, T, et al.
Publicado: (1999)

Recent therapeutic advances in chronic lymphocytic leukemia
por: Bose, Prithviraj, et al.
Publicado: (2017)

Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia
por: Gimenez, Neus, et al.
Publicado: (2020)

Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia
por: Alsagaby, Suliman A., et al.
Publicado: (2019)

Current concepts in diagnosis and treatment of chronic lymphocytic leukemia
por: Hus, Iwona, et al.
Publicado: (2015)

Chronic Lymphocytic Leukemia with Dermatomyositis: A Therapeutic Challenge
por: Kumar, Sudhir, et al.
Publicado: (2020)

NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
por: Sportoletti, Paolo, et al.
Publicado: (2021)

Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges
por: Perutelli, Francesca, et al.
Publicado: (2022)

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia
por: Masternak, Marta, et al.
Publicado: (2020)

Therapeutic Strategies of Biologics in Chronic Rhinosinusitis: Current Options and Future Targets
por: Tai, Junhu, et al.
Publicado: (2022)

Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients
por: Karabon, L., et al.
Publicado: (2020)

Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role
por: Allegra, Alessandro, et al.
Publicado: (2020)

PB1914: UNPRECEDENTED ACCUMULATION OF 5-HYDROXYMETHYLURACIL IN CHRONIC LYMPHOCYTIC LEUKEMIA –POTENTIAL SOURCES AND CLINICAL IMPLICATIONS
por: Gackowski, Daniel, et al.
Publicado: (2023)

Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia
por: Mancikova, Veronika, et al.
Publicado: (2021)

Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia
por: Sarris, Katerina, et al.
Publicado: (2013)

Clinical and Biological Relevance of Genomic Heterogeneity in Chronic Lymphocytic Leukemia
por: Friedman, Daphne R., et al.
Publicado: (2013)

CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance
por: D’Arena, Giovanni, et al.
Publicado: (2020)

PB1856: DEMETHYLATING AGENTS AND HISTONE DEACETYLASE INHIBITORS AS NEW THERAPEUTIC STRATEGIES IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Jorge #, J., et al.
Publicado: (2022)

Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia
por: Forconi, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0ffjqa9oqduu4csjd7li8s6qhu